Lucca, F.; Volpi, S.; Ros, M.; Fabrizzi, B.; Meneghelli, I.; Bordicchia, M.; Buniotto, F.; Lancini, A.; Brignole, C.; Pauro, F.;
et al. Elexacaftor/Tezacaftor/Ivacaftor Efficacy in a Cohort of Italian Patients with CFTR Rare Mutations. Int. J. Transl. Med. 2025, 5, 11.
https://doi.org/10.3390/ijtm5010011
AMA Style
Lucca F, Volpi S, Ros M, Fabrizzi B, Meneghelli I, Bordicchia M, Buniotto F, Lancini A, Brignole C, Pauro F,
et al. Elexacaftor/Tezacaftor/Ivacaftor Efficacy in a Cohort of Italian Patients with CFTR Rare Mutations. International Journal of Translational Medicine. 2025; 5(1):11.
https://doi.org/10.3390/ijtm5010011
Chicago/Turabian Style
Lucca, Francesca, Sonia Volpi, Mirco Ros, Benedetta Fabrizzi, Ilaria Meneghelli, Marica Bordicchia, Francesca Buniotto, Alessia Lancini, Cecilia Brignole, Francesca Pauro,
and et al. 2025. "Elexacaftor/Tezacaftor/Ivacaftor Efficacy in a Cohort of Italian Patients with CFTR Rare Mutations" International Journal of Translational Medicine 5, no. 1: 11.
https://doi.org/10.3390/ijtm5010011
APA Style
Lucca, F., Volpi, S., Ros, M., Fabrizzi, B., Meneghelli, I., Bordicchia, M., Buniotto, F., Lancini, A., Brignole, C., Pauro, F., Bezzerri, V., & Cipolli, M.
(2025). Elexacaftor/Tezacaftor/Ivacaftor Efficacy in a Cohort of Italian Patients with CFTR Rare Mutations. International Journal of Translational Medicine, 5(1), 11.
https://doi.org/10.3390/ijtm5010011
